Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
19.30
+0.26 (1.37%)
Aug 1, 2025, 3:00 PM CST
Shanghai Pharmaceuticals Holding Employees
Shanghai Pharmaceuticals Holding had 49,402 employees as of December 31, 2024. The number of employees increased by 1,238 or 2.57% compared to the previous year.
Employees
49,402
Change (1Y)
1,238
Growth (1Y)
2.57%
Revenue / Employee
$5,583,998
Profits / Employee
$87,918
Market Cap
64.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49,402 | 1,238 | 2.57% |
Dec 31, 2023 | 48,164 | 287 | 0.60% |
Dec 31, 2022 | 47,877 | 821 | 1.74% |
Dec 31, 2021 | 47,056 | -1,080 | -2.24% |
Dec 31, 2020 | 48,136 | 358 | 0.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Jiangsu Hengrui Medicine | 20,238 |
Shenzhen Mindray Bio-Medical Electronics | 21,667 |
WuXi AppTec | 39,414 |
Sichuan Biokin Pharmaceutical | 2,521 |
Zhangzhou Pientzehuang Pharmaceutical., | 2,839 |
Aier Eye Hospital Group | 42,693 |
Shanghai United Imaging Healthcare | 8,173 |
Yunnan Baiyao Group Co.,Ltd | 9,277 |
Shanghai Pharmaceuticals Holding News
- 7 months ago - Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million - Benzinga
- 7 months ago - HUTCHMED to divest 45% stake in JV with Shanghai Pharma - Seeking Alpha